| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/23/1999 | US5874083 Proteins and complexes for immune response |
| 02/23/1999 | US5874082 Humanized anti-CD40 monoclonal antibodies and fragments capable of blocking B cell proliferation |
| 02/23/1999 | US5874081 Therapeutic compositions and methods for inhibition and treatment of tumor associated angiogenesis |
| 02/23/1999 | US5874080 Administering a therapeutic polypeptide antiallergens to inhabit elastase release by neutrophils |
| 02/23/1999 | CA1340409C Functionally specific antibodies |
| 02/23/1999 | CA1340403C Human b lymphotropic virus (hblv) isolation and products |
| 02/23/1999 | CA1340401C Cell surface protein, process for its preparation, and the use of a cell surface protein thus obtained |
| 02/21/1999 | CA2241428A1 Asp5 |
| 02/20/1999 | CA2241429A1 Cxcr4b: a human splice variant of cxcr4 chemokine receptor |
| 02/20/1999 | CA2213385A1 Method of protecting against coccidiosis infections in poultry |
| 02/19/1999 | CA2241433A1 Novel compounds |
| 02/19/1999 | CA2240631A1 Pigr-1, a member of immunoglobulin gene superfamily |
| 02/18/1999 | WO1999007869A1 Live recombinant vaccine comprising inefficiently or non-replicating virus |
| 02/18/1999 | WO1999007861A1 DNA INTEGRATION INTO 'MYCOBACTERIUM spp.' GENOME BY TRANS-COMPLEMENTATION USING A SITE-SPECIFIC INTEGRATION SYSTEM |
| 02/18/1999 | WO1999007860A1 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/18/1999 | WO1999007859A1 Replication-competent recombinant sabin type 1 strain of poliovirus |
| 02/18/1999 | WO1999007856A1 Novel metalloprotease |
| 02/18/1999 | WO1999007855A1 Neutral sphingomyelinase |
| 02/18/1999 | WO1999007854A2 Serine/threonine kinase, and uses related thereto |
| 02/18/1999 | WO1999007852A1 Vaccine against fowlpox virus |
| 02/18/1999 | WO1999007840A1 Secreted proteins and polynucleotides encoding them |
| 02/18/1999 | WO1999007839A2 Immunoprotective influenza antigen and its use in vaccination |
| 02/18/1999 | WO1999007741A1 Meningococcus vaccine comprising the valence of bz83 strain |
| 02/18/1999 | WO1999007737A2 Lsr receptor, cloning and uses |
| 02/18/1999 | WO1999007736A2 Lipoprotein-regulating medicaments |
| 02/18/1999 | WO1999007726A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 02/18/1999 | WO1999007414A1 Vectors derived from antibodies for transferring substances into cells |
| 02/18/1999 | WO1999007405A1 TREATMENT OF ACUTE LUNG INJURY AND FIBROSIS WITH ANTAGONISTS OF αvβ6 |
| 02/18/1999 | WO1999007395A1 Polygala senega compositions and methods of use |
| 02/18/1999 | WO1999007340A1 Aqueous aerosol preparations containing biologically active macromolecules and method for producing the corresponding aerosols |
| 02/18/1999 | WO1998051279A3 Method of making microencapsulated dna for vaccination and gene therapy |
| 02/18/1999 | WO1998014593A3 Human telomerase catalytic subunit |
| 02/18/1999 | DE19733651A1 Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole Aqueous aerosol formulations containing biologically active molecules Marko and method for generating appropriate aerosols |
| 02/18/1999 | CA2300977A1 Neutral sphingomyelinase |
| 02/18/1999 | CA2299630A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 02/18/1999 | CA2298849A1 Lipoprotein-regulating medicaments |
| 02/18/1999 | CA2298840A1 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/18/1999 | CA2298451A1 Secreted proteins and polynucleotides encoding them |
| 02/18/1999 | CA2297736A1 Treatment of acute lung injury and fibrosis with antagonists of .alpha.v.beta.6 |
| 02/18/1999 | CA2297174A1 Aqueous aerosol preparations containing biologically active macromolecules and process for producing the corresponding aerosols |
| 02/18/1999 | CA2274302A1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications |
| 02/18/1999 | CA2268737A1 Replication-competent recombinant sabin type 1 strain of poliovirus |
| 02/18/1999 | CA2267066A1 Meningococcus vaccine comprising the valence of bz83 strain |
| 02/17/1999 | EP0897011A2 Novel arginine deiminase |
| 02/17/1999 | EP0897008A2 His5 |
| 02/17/1999 | EP0897007A2 MraY transferase |
| 02/17/1999 | EP0897004A2 Histidyl tRNA synthetase from Streptococcus pneumoniae (hisS) |
| 02/17/1999 | EP0897002A2 U62317, a protein having a JNK-binding domain |
| 02/17/1999 | EP0896626A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system |
| 02/17/1999 | EP0896623A1 Immunity to trypanosomatids species |
| 02/17/1999 | EP0896615A1 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator |
| 02/17/1999 | EP0896586A1 ErbB3 ANTIBODIES |
| 02/17/1999 | EP0896585A1 Humanized anti-cd40 monoclonal antibodies and fragments capable of blocking b cell activation |
| 02/17/1999 | EP0896584A2 BIOLOGICALLY ACTIVE PROTEIN (COLLAGEN FRAGMENT HF-COLL-18/514cf) FOR INHIBITING THE GROWTH OF TUMOURS AND CAPILLARY PROFILERATIONS |
| 02/17/1999 | EP0896583A1 Novel osp-c derived peptide fragments |
| 02/17/1999 | EP0896582A1 Non-dendritic backbone peptide carrier |
| 02/17/1999 | EP0896543A1 Drug for the treatment of tumours |
| 02/17/1999 | EP0896538A1 Use of dipeptidyl peptidase iv inhibitors for lowering the blood glucose level in mammals |
| 02/17/1999 | EP0896506A1 Methods for inducing immune responsiveness in a subject |
| 02/17/1999 | CN1208436A Novel polypeptide originating in hemophilus paragallinarum and process for producing the same |
| 02/17/1999 | CN1207946A Thioether conjugates |
| 02/16/1999 | US5872234 Antitumor |
| 02/16/1999 | US5872226 Fibroblast growth factor homologous factor-1 (FHF-1) |
| 02/16/1999 | US5872221 Capable of binding epitopes of pthrp and a kit for the detection of pthrp or fragments thereof comprising one or more antibody reagents capable of binding to epitopes of pthrp |
| 02/16/1999 | US5872220 Antibodies to insulin-like growth factor binding protein IGFBP-6 |
| 02/16/1999 | US5872218 Monoclonal antibodies |
| 02/16/1999 | US5872210 Used in the treatment of virally infected cells, in the preparation of vaccine formulations, in the generation of clinically relevant antibodies and anti-idiotypic antibodies and in the generation of a screening assay or kit that can be |
| 02/16/1999 | US5872154 Method of reducing an immune response to a recombinant adenovirus |
| 02/16/1999 | US5872096 Modified sialyl Lewisa compounds |
| 02/16/1999 | US5872013 Universally applicable detection system based on ultra small colloidal metal particles |
| 02/16/1999 | US5872012 Protamine-reactive IGM antibodies |
| 02/16/1999 | US5871998 Gene expression in transformed eukaryotic host cell; genetic engineering |
| 02/16/1999 | US5871996 First agent comprising isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg |
| 02/16/1999 | US5871990 UDP-N-acetyl-α-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase, gAlnAc-T3 |
| 02/16/1999 | US5871989 Phenylalanyl tRNA synthetase alpha subunit polynucleotides from streptococcus pneumoniae |
| 02/16/1999 | US5871973 Cell division regulators |
| 02/16/1999 | US5871967 Cloning of a novel G-Protein coupled 7TM receptor |
| 02/16/1999 | US5871962 Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods |
| 02/16/1999 | US5871961 Nucleic acids encoding CR2 polypeptides, vector and transformed cell thereof, and expression thereof |
| 02/16/1999 | US5871960 Nucleic acids encoding CR5 polypeptide, vector and transformed cell thereof, and expression thereof |
| 02/16/1999 | US5871943 Immunoassay comprising a truncated pneumococcal surface protein A (PspA) |
| 02/16/1999 | US5871934 Screening methods using cytokine suppressive anti-inflammatory drug (CSAID) binding proteins |
| 02/16/1999 | US5871933 Diagnosing, screening, and confirming infection with accuracy; vaccines |
| 02/16/1999 | US5871931 Methods for detecting mammalian tub protein and RNA |
| 02/16/1999 | US5871903 HCV isolates |
| 02/16/1999 | US5871767 Implanting in patient immunoisolatory vehicle comprising core containing living cells which secrete biologically active material dispersed in biocompatible matrix, surrounded by biocompatible external jacket |
| 02/16/1999 | US5871751 Oral vaccine for infection from renibacterium |
| 02/16/1999 | US5871750 Leukotoxin vaccine compositions and uses thereof |
| 02/16/1999 | US5871749 Therapeutic treatment of H. pylori associated gastroduodenal disease |
| 02/16/1999 | US5871748 Administering to the subject a vaccine complex comprising a live vaccine virus and antibodies bound to said live vaccine virus |
| 02/16/1999 | US5871747 Antigen-carrying microparticles and their use in the indication of humoral or cellular responses |
| 02/16/1999 | US5871746 For immunizing against pathogenic agents such as viruses orparasites; one or more chains derived from fatty acids or modified steroid groups |
| 02/16/1999 | US5871745 Isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg |
| 02/16/1999 | US5871744 Method for generating birnavirus from synthetic RNA transcripts |
| 02/16/1999 | US5871742 Dna codes for polypeptides with amino acid sequences |
| 02/16/1999 | US5871738 Nematode vaccine |
| 02/16/1999 | US5871737 Methods for treating a fibrin encapsulated tumor using a fibrin specific monoclonal antibody and compositions used therein |
| 02/16/1999 | US5871736 Liquid immunoglobulin formulations |
| 02/16/1999 | US5871735 Isoferritin as a marker for pathological pregnancy |
| 02/16/1999 | US5871732 Dna sequences and genetic engineering for aids |